Tianshu Zeng Selected Research

Tianshu Zeng Research Topics

Disease

9	Insulin Resistance 01/2022 - 06/2014
7	COVID-19 11/2021 - 01/2020
7	Inflammation (Inflammations) 01/2021 - 01/2016
6	Obesity 01/2022 - 03/2016
5	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2015
4	Non-alcoholic Fatty Liver Disease 11/2021 - 03/2016
3	Body Weight (Weight, Body) 11/2021 - 07/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2021
2	Neoplasms (Cancer) 01/2022 - 11/2021
2	Prediabetic State (Prediabetes) 01/2022 - 11/2021
2	Diabetic Nephropathies (Diabetic Nephropathy) 11/2021 - 01/2015
2	Infections 01/2021 - 01/2020
2	Atherosclerosis 01/2020 - 01/2020
2	Graves Disease (Basedow Disease) 12/2017 - 11/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Fibrosis (Cirrhosis) 11/2021
1	Alcoholism (Alcohol Abuse) 11/2021
1	Chronic Renal Insufficiency 11/2021
1	Fatty Liver 11/2021
1	Hyperuricemia 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021
1	Macular Edema 01/2021
1	Gout 01/2021
1	Pathologic Neovascularization 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2020
1	Hyperglycemia 01/2020
1	Body Weight Changes 02/2018
1	Ischemia 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2017

Drug/Important Bio-Agent (IBA)

9	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2018
4	LipidsIBA 01/2022 - 01/2018
4	Insulin (Novolin)FDA Link 01/2022 - 07/2017
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 07/2017
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
3	Blood Glucose (Blood Sugar)IBA 10/2020 - 02/2018
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 01/2015
2	HDL CholesterolIBA 01/2022 - 01/2021
2	FructoseIBA 01/2021 - 10/2020
2	AMP-Activated Protein KinasesIBA 01/2020 - 03/2016
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2014
2	Adenosine (Adenocard)FDA LinkGeneric 12/2018 - 01/2018
2	CytokinesIBA 12/2018 - 03/2016
2	AdiponectinIBA 01/2015 - 01/2015
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	CholesterolIBA 01/2022
1	AndrostenediolIBA 01/2022
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	VitaminsIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	SteroidsIBA 01/2022
1	Alanine (L-Alanine)FDA Link 01/2022
1	LDL CholesterolIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	NucleotidesIBA 01/2022
1	glycylvalineIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 11/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2021
1	BIBO 3304IBA 11/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2021
1	ElementsIBA 11/2021
1	Alanine Transaminase (SGPT)IBA 11/2021
1	InsulinsIBA 03/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2021
1	Uric Acid (Urate)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Histones (Histone)IBA 12/2020
1	Vascular Endothelial Growth Factor BIBA 12/2020
1	indoleIBA 10/2020
1	bafilomycin A1IBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	Interleukin-1 Receptor-Associated KinasesIBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	C-Reactive ProteinIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	GlucosidasesIBA 01/2020
1	Caveolin 1IBA 01/2020
1	ProcalcitoninIBA 01/2020
1	Class III Phosphatidylinositol 3-KinasesIBA 01/2020
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2020
1	alogliptinIBA 02/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018
1	EndotoxinsIBA 01/2018
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2018
1	CTLA-4 AntigenIBA 12/2017
1	Interleukin-6 (Interleukin 6)IBA 11/2017

Therapy/Procedure

1	Glycemic Control 11/2021
1	Caloric Restriction 12/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Therapeutics 02/2018